Navigation Links
Unity Management Group, MCC Receives Authorization for Second Purchase Order From Bristol Meyers Squibb
Date:7/5/2011

EAST HANOVER, N.J., July 5, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) "UNITY" (or the "Company")  (MCC) Metropolitan Computing Corporation has received authorization for a second purchase order to come in this week from Bristol Meyers Squibb, BMS Pharmaceuticals LTD., one of the largest pharmaceutical companies ,for  $108,000.00 . MCC completed installation on the first order from Bristol Meyers Squibb UK, with successful results, using their complete instrumentation and calibration services to upgrade preexisting equipment with MCC's proprietary Advanced Instrumentation Monitor technology (AIM).  

The MCC instrumentation monitoring system is engineered to integrate hardware and software into a complete data acquisition and analysis system. AIM is a state-of-the-art tool that facilitates research, process development, scale-up, and production of tablets and capsules. It is Windows NT based and provides continuous batch recordings and process optimization for all instrumented equipment. The system is modular and is contained in a mobile enclosure or laptop computer that can be moved between different types of instrumented equipment. Each system can be custom tailored to match customer specific needs.

"We continue to improve, and expand our company with this second order from BMS LTD," said Ron Berman President. "We are continuing to expand our range of development and becoming the leader in our industry. With the consolidation and streamlining of the entire major pharmaceutical companies today our abilities to upgrade existing equipment, to save time and expense has become very valuable."

About Bristol Meyers Squibb:

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers' needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs. The strategy is working. For the past three years, our total return for shareholders, including dividends, has been among the best in the industry. We outperformed most mega pharma companies, diversified companies and pure biotech companies. Reflecting our long-standing commitment to deliver shareholder value, our company has paid dividends to stockholders for more than 300 consecutive quarters.Net Sales:$19.5 billion in 2010R&D Investment:$3.6 billion in 20102010 Largest-Selling Products:PLAVIX®, $6.7 billion

ABILIFY®, $2.6 billion

REYATAZ®, $1.5 billion

AVAPRO®/AVALIDE®, $1.2 billion

SUSTIVA® franchise, $1.4 billion

BARACLUDE®, $931 millionwww.bms.com

About Unity Management Group, Inc.: Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPAA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physicians' offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company will be providing medical, vision and dental plans, as well as PPO and HMO networks.

For more information please go to our website which can be found at

www.unitymanagementgroup.com
www.mcc-online.com

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company's inability to accurately forecast its operating results; the Company's potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company's business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

Unity Management Group, Inc. Investor Relations 855-413-0755


'/>"/>
SOURCE Unity Management Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Austen BioInnovation Institute in Akron Begins Work on Roadmap for First U.S. Accountable Care Community
2. Designed by Kids, Built by Volunteers: Roche, New Jersey Community Development Corporation, and KaBOOM! Build New Playground in Just One Day for Paterson Public School Children
3. From GED to PhD: Borough of Manhattan Community Colleges Brian Olson Faces Academic Deficits Only to Be Rewarded with Acceptance to CUNYs PhD Program in Biochemistry
4. DATATRAK Academy Expands to Include Durham Technical Community College
5. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
6. EMC Isilon Customers Discuss the Big Data Opportunity in Life Sciences at Bio-IT World Conference 2011
7. DuPont Leader: Renewables at the Heart of Clean Technology Market Opportunity
8. Four Community Hospitals Join DNA Directs Genomic Medicine Network
9. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
10. Bunker Hill Community College Wins Major Endorsement for Biotechnology Courses
11. Epizyme identifies novel opportunity for treatment of genetically defined human B-cell lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing ... MPH, will present information about the company,s programs at the BIOCEO ... New York City . --> ... 5:30PM EST. Registered attendees can request a one on one meeting ... --> New York City . ...
(Date:2/8/2016)... -- --> --> ... ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it ... test to be launched on the Company,s io® platform. By ... test is now cleared for sale within the European Union. ... of the io® CT test signals a new era in ...
(Date:2/5/2016)... , Feb. 5, 2016 ATCC, the ... poised to assist the medical and life science researchers ... Zika Virus infection.   CDC website . ... --> Zika virus is a single-stranded RNA virus ... the West Nile, Dengue and Chikungunya Viruses. Zika virus ...
(Date:2/5/2016)... SAN FRANCISCO , February 5, 2016 ... AMBS), a biotechnology company focused on developing products ... it has requested Rare Pediatric Disease Designation (RPDD) from ... retinitis pigmentosa (RP) with MANF. MANF was previously granted ... December 2014. --> Amarantus BioScience Holdings, Inc. ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... , Feb. 2, 2016 Checkpoint ... that Rising Market Are you interested in ... forecasts revenues for checkpoint inhibitors. Visiongain,s report gives ... submarket, product and national level. Avoid falling ... what progress, opportunities and revenues those emerging cancer ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
Breaking Biology News(10 mins):